{'fraction_non_alphanumeric': 0.021621621621621623, 'fraction_numerical': 0.010810810810810811, 'mean_word_length': 5.3125, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Nursing the canine myasthenic patient

Michelle qualified as a veterinary nurse in 1995. She holds both the surgical and medical diplomas in Advanced Veterinary Nursing and the Certificate in Emergency and Critical Care Nursing. Her experience within the field of veterinary nursing is extensive, ranging from general practice to referral nursing both in the UK and USA. She is passionate about veterinary nursing and education. In 2011 she proudly launched a unique veterinary nursing in-house CPD Company – The Veterinary Nursing Consultancy – bringing CPD and training where it is needed most – with the patients and veterinary staff across the UK. Myasthenia gravis (MG) is a condition resulting from a deficiency of nicotinic acetylcholine (ACh) receptors on the postsynaptic membrane of skeletal muscle. The resulting impairment of neuromuscular transmission is clinically manifested as muscle weakness. Dewey (1997) reported MG in dogs, cats and in humans. Acquired (immune mediated) myasthenia gravis is characterised by the antibody-mediated destruction of ACh receptors at the neuromuscular junction.